Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1996-9-26
|
pubmed:abstractText |
Long-term H. pylori associated gastritis is recognized as a pathogenic factor in gastric carcinogenesis. In gastric carcinomas the amount and activity of the tissue-type plasminogen activator (t-PA) have been reported to be decreased, whereas those of the urokinase-type plasminogen activator (u-PA) were increased, contributing to the neoplastic and invasive process. The present study was performed to determine t-PA and u-PA levels and activity in gastric mucosa from 102 patients and to investigate whether these levels are influenced by H. pylori infection. The antigen concentration and activity of t-PA and u-PA in corpus mucosa were low (P < 0.001) compared with those in antral mucosa, although for the u-PA activity this did not reach statistical significance. In H. pylori-associated antral gastritis the mucosal t-PA antigen concentration and activity were found to be decreased (P < 0.001) compared with normal mucosa, whereas in H. pylori-associated pangastritis the corpus t-PA levels were not affected. The antigen concentration and activity of u-PA were found to be significantly (P < 0.005) increased, both in H. pylori-associated gastritis of antrum and corpus mucosa. Levels of u-PA in histologically normal corpus mucosa of patients with an H. pylori-associated antral gastritis were also found to be increased (P < 0.05). In conclusion, the alterations in the plasminogen activator profile found in H. pylori-associated gastritis, ie, a decrease in t-PA and an increase in u-PA, show a similar tendency as the previously found alterations in gastric carcinomas, which provides additional support for the possible involvement of H. pylori-associated gastritis in the pathogenesis of gastric carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0163-2116
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1577-82
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8769282-Adolescent,
pubmed-meshheading:8769282-Adult,
pubmed-meshheading:8769282-Aged,
pubmed-meshheading:8769282-Aged, 80 and over,
pubmed-meshheading:8769282-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8769282-Female,
pubmed-meshheading:8769282-Gastric Mucosa,
pubmed-meshheading:8769282-Gastritis,
pubmed-meshheading:8769282-Helicobacter Infections,
pubmed-meshheading:8769282-Helicobacter pylori,
pubmed-meshheading:8769282-Humans,
pubmed-meshheading:8769282-Male,
pubmed-meshheading:8769282-Middle Aged,
pubmed-meshheading:8769282-Pyloric Antrum,
pubmed-meshheading:8769282-Tissue Plasminogen Activator,
pubmed-meshheading:8769282-Urokinase-Type Plasminogen Activator
|
pubmed:year |
1996
|
pubmed:articleTitle |
Gastric mucosal plasminogen activators in Helicobacter pylori infection.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, University Hospital Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article
|